Three potentially fatal adverse effects of psychotropic medications.
Wren
Pamelia
P
School of Nursing, University of Alabama, Birmingham, AL, USA.
Frizzell
Laura A
LA
Keltner
Norman L
NL
Wright
Amy V
AV
D000380:Agranulocytosis / Q000139:chemically induced* / Q000401:mortality / Q000517:prevention & control; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists / Q000009:adverse effects; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control; D024802:Nurse's Role; D010353:Patient Education as Topic; D018579:Patient Selection; D011568:Psychiatric Nursing / Q000379:methods; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012307:Risk Factors; D012701:Serotonin / Q000502:physiology; D012702:Serotonin Antagonists / Q000009:adverse effects; D020230:Serotonin Syndrome / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D011619:Psychotropic Drugs; D012702:Serotonin Antagonists; D012701:Serotonin; D003024:Clozapine; D004298:Dopamine